510.545.6984 
--
|
"It’s important to provide licensed Cannabis dispensaries with a safe resource for buying laboratory |
|
CW helps ensure the consistency of our products. Their expertise in both food and cannabis science has been critical to the success of our chocolates. |
|
“CW Analytical’s scientific testing services provide a greater level of assurance to our patients that |
Project CBD is a not-for-profit, educational service dedicated to promoting and publicizing research into the unique medical properties of cannabidiol (CBD) and other components of the cannabis plant. CW Analytical Laboratories is proud to be part of Project CBD. Visit Project CBD at www.projectcbd.com.
The American Herbal Products Association (AHPA) is the only national trade association that is focused primarily on products containing herbs, which includes dietary supplements, cosmetics, nutraceuticals, and other related natural products. All of AHPA’s activities are focused on its mission, to promote the responsible commerce of herbal products, and are undertaken to maintain and improve market opportunities for companies that sell products that contain herbs, and to ensure that consumers continue to enjoy informed access to a wide choice of goods. More
As the "Association of Analytical Communities,” AOAC INTERNATIONAL is committed to being a proactive, worldwide provider and facilitator in the development, use, and harmonization of validated analytical methods and laboratory quality assurance programs and services. AOAC also serves as the primary resource for timely knowledge exchange, networking, and high-quality laboratory information for its members and customers. More
Despite the ongoing political debate regarding the legality of medicinal marijuana, clinical investigations of the therapeutic use of cannabinoids are now more prevalent than at any time in history. A search of the National Library of Medicine's PubMed website quantifies this fact. A keyword search using the terms "cannabis, 1996" (the year California voters became the first of 13 states to allow for the drug’s medical use under state law) reveals just 258 scientific journal articles published on the subject during that year. Perform this same search for the year 2008, and one will find over 2,100 published scientific studies. More...
The Center for Medicinal Cannabis Research will conduct high quality scientific studies intended to ascertain the general medical safety and efficacy of cannabis products and examine alternative forms of cannabis administration. The Center will be seen as a model resource for health policy planning by virtue of its close collaboration with federal, state, and academic entities. More...
The American Medical Association (AMA) voted today to reverse its long-held position that marijuana be retained as a Schedule I substance with no medical value. The AMA adopted a report drafted by its Council on Science and Public Health (CSAPH) entitled, "Use of Cannabis for Medicinal Purposes," which affirmed the therapeutic benefits of marijuana and called for further research. The CSAPH report concluded that, "short term controlled trials indicate that smoked cannabis reduces neuropathic pain, improves appetite and caloric intake especially in patients with reduced muscle mass, and may relieve spasticity and pain in patients with multiple sclerosis." Furthermore, the report urges that "the Schedule I status of marijuana be reviewed with the goal of facilitating clinical research and development of cannabinoid-based medicines, and alternate delivery methods." More ...
MAPS’ goal is to initiate and fund a serious drug development research program aimed at proving to the satisfaction of FDA that marijuana is safe and efficacious for specific medical uses and should become a legal, FDA-approved prescription medicine. While MAPS has recently been hindered by United States government agencies in attempts to conduct clinical trials using medical marijuana - MAPS will ultimately achieve its goal.More ...
Pro solutions for the perfect harvest. More...